Back to Journals » Research and Reports in Tropical Medicine » Volume 16
Clinical Features and Outcomes of Scorpion Sting in Western Lowlands of Eritrea: A Prospective Study
Authors Frezgi O
, Berhane A, Tewelde AG, Ghebrewelde G, Tekie H, Kiflezgi T, Aziz AM, Teklemariam HM, Tekie Y, Alem A, Wohabey HA
Received 7 June 2025
Accepted for publication 5 December 2025
Published 17 December 2025 Volume 2025:16 Pages 125—135
DOI https://doi.org/10.2147/RRTM.S536683
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Dr Mario Rodríguez-Pérez
Okbu Frezgi,1,2 Araia Berhane,3 Adiam G Tewelde,4 Ghide Ghebrewelde,5 Henok Tekie,5 Tsegezab Kiflezgi,5 Abdulaziz Mohammedseid Aziz,5 Habtemichael M Teklemariam,5 Yonas Tekie,5 Abel Alem,5 Hagos Ahmed Wohabey6
1Gynecology and Obstetrics, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea; 2Gynecology and Obstetrics, Orotta College of Medicine and Health Sciences, Asmara, Eritrea; 3Communicable Disease Control Division, Ministry of Health, Asmara, Eritrea; 4Integrated Disease Response and Surveillance, Ministry of Health, Asmara, Eritrea; 5Tesseney Hospital, Ministry of Health, Gash Barka, Eritrea; 6Statistical Data Processing, Eritrean National Statistics Office, Asmara, Eritrea
Correspondence: Okbu Frezgi, Email [email protected]
Background: Scorpion envenomation is a global health problem that results in life-threatening medical emergencies in the tropical and subtropical regions. Pediatric victims are at a higher risk of severe envenomation than are adults.
Objective: This study aimed to determine the clinical features and outcomes of patient’s hospitalized for scorpion stings at Tesseney Community Hospital.
Material and Methods: A prospective, descriptive, cross-sectional study was conducted from 1st June 2019 to 31st May 2020 in patients hospitalized due to scorpion stings at the Tesseney Community Hospital.
Results: About 165 scorpion-sting patients were admitted during the study period. The majority of cases were older than 15 years (61.8%) with an approximately equal male-to-female sex ratio (0.94:1), and the scorpion sting cases largely occurred in urban areas (57%) compared to rural areas. The black scorpion (38.8%) was the predominant scorpion; however, in some cases, the scorpion color was undetermined (31.5%). The foot was the predominant sting site (64.8%), followed by the hand (31.5%). Single stings (91.5%) were more frequent than multiple stings (8.5%). The majority (94.8%) of scorpion sting cases occurred during summer, with the highest scorpion sting cases occurring in September and October. The main clinical manifestations upon presentation were localized pain (70.3%) and sweating (56.4%), with more severe symptoms exhibited among age groups less than 15 years. The fatality rate (4.8%) was largely associated with age groups less than 15 years and class three scorpion stings.
Conclusion: Our study found that children experienced more severe envenoming symptoms and related mortality than adults did. This study may be a tool to identify at-risk population groups and build measures to prevent scorpion stings within the western lowlands of Eritrea.
Keywords: scorpion sting, envenomation, clinical features, Eritrea
Introduction
Scorpion stings are a life-threatening medical emergency with frequent presentations within ED department in many areas of the world.1 Accurate global statistical evidence on scorpion stings are not readily available, but the literature indicates that all settings are usually affected by this medical threat.2 In 2018, WHO reported that the true scorpion sting envenomation burden is not known because many accidents occur in villages within tropical and subtropical countries where victims likely do not seek medical attention.3 It is estimated that 1.23 million scorpion stings occur per year with roughly 3250 deaths per year.1,2,4–6 Developing countries are often reported with higher scorpion envenomation accidents and related mortality compared to developed countries due to lower socioeconomic structures and inadequately equipped health facilities.2 Pediatric victims are more at risk to severe envenomation with related mortality compared to adults due to their small body size.4,7
Scorpions are predatory arachnids with four pairs of legs, a pair of grasping pedipalps, and a narrow-segmented tail with a characteristic curved back-ending and venomous sting.5 Currently, there are more than 1500 subspecies of scorpions are recognized worldwide, with 50 subspecies having dangerous venom for humans.4,8 The Parabuthus (western and southern Africa), Hottentotta (south Africa and south-east Asia), Leiurus (northern Africa and middle East), and Androctonus (northern Africa and southeast Asia) scorpion species are reported to be found within the African continent.5 Within East Africa, scorpion sting cases are common in the central-west regions of Sudan owing to their geographical location, climate, and socioeconomic structure.8,9 Diverse color of scorpions had been identified though there is no ecological survey of scorpion species (Figure 1).
|
Figure 1 Unidentified yellow (left) and black (right) colored scorpions found within Tesseney, Eritrea obtained by data collectors. |
Scorpion venom is composed of complex structures comprising neurotoxic proteins, acidic proteins, salts, and organic compounds, with variable compositions and lethality among subspecies.4,5,8 Venom mainly affects the neurological, cardiovascular, respiratory, haematologic, and renal systems, with local effects around the sting site (ie redness, pain, swelling, and burning).4,8 Toxins and enzymes within venom exert neurological tropism effects that act on voltage-gated sodium and potassium ion channels in excitable cells of nerves and muscles.5 Venom from the same scorpion can contain multiple toxins that can interact with each other, modulating the response of the ion channels involved and leading to complex, rapidly progressive symptoms.5–8,10–12 The main effect of the venom in a victim is to mediate ion channels for intense, persistent depolarization of autonomic nerves, leading to massive discharges of neurotransmitters from both autonomic nervous system branches.5 This is referred to as an autonomic storm, owing to the sudden pouring of endogenous catecholamines into the circulation.5,11–14 The effects of an autonomic storm are seen throughout the body, but are more serious on the cardiovascular and respiratory systems leading to arrhythmia, hypertension or hypotension, and pulmonary edema.15 Clinically, autonomic storm evoked by scorpion envenoming is characterised by transient parasympathetic stimulation (vomiting, profuse sweating, ropy salivation, bradycardia, ventricular premature contraction, priapism in males, and hypotension) and prolonged sympathetic stimulation (cold extremities, hypertension, tachycardia, pulmonary oedema, and shock).5,16–19
The signs and symptoms of scorpion stings are divided into three classes, commonly known as Abroug classification.4–6,8,11,14,20 Majority of scorpion sting cases only require supportive therapy, including ibuprofen, cleaning of the sting area, and tetanus prophylaxis. In certain areas of the world where scorpions are more poisonous (eg the Middle East), scorpion stings are treated with drugs and methods that reduce symptoms and complications.21 Over the course of the 20th century, scorpion antivenom (SAV), vasodilators, and intensive care facilities have significantly reduced the fatality rate of severe scorpion envenomation.5 Administering SAV can neutralise unbound circulating venom to reduce the probability of sympathetic nervous system overstimulation.5 Though the benefits of SAV have been proven in some studies, its effectiveness continues to be debated.4,5,19,22 A critical component of scorpion sting pathogenesis is alpha-receptor stimulation.5,14 Prazosin is an α1-blocker, commonly known as a pharmacological and physiological antidote to the venom. This drug relieves serious breathing difficulties caused by high blood pressure.5,12 The drug reduces blood pressure by reducing preload and left ventricular impedance without increasing heart rate.5 Previous studies have recommended prazosin as a first-line treatment for patients arriving at the ED with scorpion envenoming, owing to the high availability of drugs in rural settings.12,23
Scorpion-sting accidents are common in the western lowlands of Eritrea which borders Sudan, and this study aimed to describe the clinical manifestations and outcomes of scorpion-sting patients admitted to Tesseney Community Hospital. Furthermore, study seeks to inform medical professionals and public health workers to design better preventive measures to reduce scorpion sting incidents in Eritrea.
Objective
Primary Objective
The study aims to provide clinical features and outcomes of patient admitted to Tesseney Community Hospital due to scorpion stings.
Secondary Objective
To describe the clinical features of scorpion stings and to determine the risk factors associated with fatal outcomes.
Materials and Methods
Study Design
This was a prospective, descriptive, cross-sectional study conducted from 1st June 2019 to 31st May 2020 on patients admitted to the Tesseney Community Hospital due to scorpion stings.
Study Area
Tesseney Hospital is a community hospital located in the Gash-Barka region of Eritrea. It serves a catchment population of 87,992 and is distributed in an area of 1096.83 km2. (Figure 2). The hospital provides inpatient and outpatient services, delivery services, laboratory services, imaging units, and physiotherapy units, and possesses a 115-bed capacity.
|
Figure 2 Map of Tesseney subzone, Eritrea. |
Study Population
All patients admitted to the hospital due to scorpion stings from 1st June 2019 to 31st May 2020 were considered the study population. Patients who had a history of scorpion sting and had seen or killed the scorpion (via a victim or bystander) were also included in the study population. Patients with a history of unknown bites, who arrived at the ED without signs of death, and/or who died after discharge from the hospital were excluded from this study.
Data Collection and Analysis
Data were collected by admitting doctors to a predesigned questionnaire survey prepared using an open data kit (ODK) and were followed until the final outcome. Demographic characteristics, vital signs, symptoms, time interval between scorpion sting incident and arrival at the hospital, and medications administered were also recorded. Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) v.23 software. The symptoms and signs were categorised into three classes according to the Abroug classification (Table 1). Abroug’s classification was used because of the catalogue’s convenience and its common use in neighbouring countries (Table 1).4–6,8,11,14,20 Descriptive data were expressed as frequency and percentage while intergroup differences were analysed using Chi-Square or Fisher test depending on the characteristics of the data (p-value < 0.05 as statistically significant).
|
Table 1 Abroug’s Classification |
Ethical Approval
This study was approved by the Zonal Office of the Ministry of Health Research and Ethics Approval Committee (reference number: 3/31/2897). Written informed consent was obtained from each patient or parent/caregiver taker for children and the study complies with the declaration of Helsinki. The confidence of the study participants was maintained by analysing anonymised aggregate data and coding personal identifiers. The patients were reassured that there was no environmental or occupational harm from participating in this study. All patients were provided with standard treatments for the disease.
Results
A total of 165 patients with scorpion stings were admitted to the Tesseney Community Hospital from 1st June 2019 to 31st May 2020. Our results showed an approximately equal male-to-female ratio of 0.94:1. The mean, median, and standard deviation of age according to sex were 26.03, 17.50 and 19.73 for males and 23.89, 20.00, 16.56 for females, respectively, for women. The majority of hospitalized patients were older than 15 years (61.2%), whereas 38.2% were younger than 15 years (Table 2). Regarding occupational frequency, shepherds (31.5%), farmers (21.2%), and students (26.9%) ranked highest, while the remainder were registered as others (21.2%).
|
Table 2 Distribution of Scorpion Sting Outcomes According to Socio-Demographic Factors in Western Lowlands of Eritrea: a Prospective Analytic Study from 1st June 2019 to 31st May 2020 (n = 165) |
The sting site was primarily located on the foot (64.8%), followed by the hands (31.5%). Regarding the time of the scorpion sting incident, 62.4% of the stings occurred at night compared with 37.6% during the day. The number of indoor stings (56.4%) was slightly higher than that of the outdoor stings (43.6%) (Table 3). Of all admitted patients, eight were deceased; thus, the case fatality rate was 4.8%. The fatality outcome was largely associated with class III scorpion stings (p = 0.088).
Patients aged <15 years (p = 0.006) and with no formal education (p = 0.008) showed a possible predisposing factor for symptom severity (Table 2). The number of stings, scorpion colour, and sex of the victim were not found to be significant risk factors for symptom severity (Table 3). According to Abroug’s classification, 43.6% cases had class three, 35.8% cases had class two, and 20.6% of patients had class one (Table 3). Children under five years of age held class III scorpion stings at presentation in 75% of cases. The most common clinical manifestations were localised pain (70.3%), sweating (56.4%), vomiting (33.9%), paraesthesia (29.2%), bradycardia (24.8%), restlessness (24.2%), fever (19.4%), and shock (3.6%) (Table 4).
Among all admitted patients, those with mild symptoms (class I) were managed with local anaesthesia (84.8%) and oral analgesics (41.4%). Patients experiencing generalised pain, restlessness, and convulsions were managed with diazepam (23.6%), with a minority requiring intravenous fluids (1.9%) or antibiotics (1.2%). Patients with moderate-to-severe symptoms (classes II–III) were managed with nifedipine and/or SAV (15.2%) (Table 5).
|
Table 5 Distribution of Treatment Options Based on Abroug’s Classification in Western Lowlands of Eritrea: a Prospective Analytic Study from 1st June 2019 to 31st May 2020 (n = 165) |
Although scorpion sting cases were common throughout the year, the highest number of cases occurred during the summer season (93%), with September and October being the leading months (Figure 3). Within the summer season, 94.8% of the patients recovered, with only seven fatalities during this period.
|
Figure 3 Annual distribution of scorpion sting cases in western lowlands of Eritrea from 1st June 2019 to 31st May 2020 (n = 165). |
Discussion
Although medical science has advanced in recent decades, scorpion envenomation has largely been ignored because of the unknown prevalence of scorpion stings and high number of low-income victims.22 Majority of scorpion sting accidents occur in villages in tropical or subtropical regions, where the victim does not fully appreciate the seriousness of the medical threat. Thus, victims rely more on traditional healers and remain unregistered in health care settings.23 The Tesseney region, an Eritrean subzonal district that borders Sudan, is an agricultural-based economy often afflicted with scorpionism among its inhabitants.
Our study had an approximately equal male-to-female ratio (0.94:1) which is in contrast to other studies that reported a higher male-to-female ratio within the Middle East and North Africa (MENA) region, where deadly scorpion stings are the most common.3,19,22 Children-based scorpionism studies conducted by Baseer et al, and Kannan et al also identified a higher male-to-female ratio compared to studies involving all age groups.24–26 These different findings can likely be attributed to the differing social and behavioral factors children and adolescents to scorpion stings rather than scientifically relevant factors. Furthermore, male are more exposed to outdoor sting as they are engaged in field work. Age groups older than 15 years were more frequently affected by scorpion stings (61.8%) than those younger than 15 years (38.2%). Young people, especially age 20–29, often have a higher scorpion sting affliction rate, as reported by Boubekeur et al and Khatony et al22,27 Older scorpion sting victims usually worked outdoors (eg shepherds or farmers) and were more likely to be exposed to scorpion habitats.
Previous epidemiologic studies have reported that sting sites are commonly located on the extremities rather than on the head or trunk.3,9,10,22,24,25,27,28 Our results align with these studies, as most sting sites were located on either the upper or lower extremities, with the majority located on the foot rather than the hand. Scorpions hiding in shoes left empty overnight or in pockets of loose clothing or trousers are common causes of stung on the hand or foot.2 Furthermore, wearing sandals instead of close-toed shoes, working in unprotected fields, and children running barefoot are common occurrences in the Gash Barka region. Lastly, our study observed that night-time stings were more common than daytime stings which is consistent with the findings of multiple studies.4,7,22,25,26,29
Warm temperatures and sunny weather are conditions that lead to a higher number of envenomation accidents. Our results indicated that the summer period had the highest scorpion sting incidence, with September and October being the leading months. Studies have shown that scorpion sting accidents are more common during the summer than during the winter or autumn.3,4,22,27 The MENA region has also reported similar conditions, with Morocco having the highest scorpion sting incidence between June and September, Saudi Arabia between May and September, and Iran between April and October.3
The clinical features of scorpion envenomation often depend on the scorpion subspecies, amount of venom injected, age and feeding characteristics of the scorpion, seasonal conditions, and time elapsed between the time of sting and hospitalisation.3,4,26 Different species of scorpions have different types of venom which may cause local and systemic effects during the first few hours.3,5,7–9,20,30,31 Until recently, only eight species of scorpions of the genus Centruroides had been considered dangerous to humans.8 Systemic manifestations (cardiovascular toxicity, respiratory failure, hypertension and hypotension, etc) are observed at various sites throughout the body and appear within the first 12–24 hours following immediate local effects around the sting site.3 Our results indicate that the most common clinical features were localized pain, sweating, and vomiting. Local pain and sweating are frequent clinical features of scorpion envenomation surveys.3,4,7,26 However, studies with differing clinical features may be attributed to scorpion subspecies relative to the region, site of sting, time elapsed from the incident until hospitalization, and/or the age of the victim. Bansal et al studied the clinical profile of scorpion stings in northern Uttar Pradesh, India, and identified tachycardia, a severe clinical manifestation, in up to a 1/5th of patients. Scarification was identified in approximately 39% of scorpions in a study by Abourazzak et al, signifying the importance of different scorpion subspecies on human health. In addition, vomiting was observed at a high frequency (73%) in a children-based study by Abourazzak et al. However, at a very low frequency (8.57%), Bansel et al, indicating that the study design can have an effect on the observed clinical features.
Our study observed class II–III manifestations among children and younger persons, with cardiac arrhythmia (manifested as relative bradycardia compared with tachycardia), shock, convulsions, and semi-consciousness being the most severe clinical features. According to Mallanagounda et al, age is one of the most important risk factors associated with scorpion envenomation with earlier symptoms after the sting and a more delayed recovery compared with older individuals. Our findings align with those of multiple studies that have reported that envenomation severity was higher in children than in adults.5,11,29,32 More severe scorpion envenomation symptoms found in children are likely attributable to their smaller body size. With a smaller body mass, venom may diffuse and act more rapidly on the autonomic nervous system; thus, they have a higher likelihood of systemic involvement, which positions a scorpion-sting victim at a higher risk of death.5,26 This was illustrated in an autopsy case report that showed that the mortality rate of untreated babies was considerably higher than that of untreated school-aged children, followed by untreated adults.33 In our study, patients younger than 15 years of age who passed away from class II–III manifestations contributed the most to the fatality rate (4.8%) and showed a predisposing risk factor (p = 0.006) for higher severity of symptoms or death.
Our results exhibited an unusually high frequency of class III envenoming symptoms (43.6%) compared with similar studies in the literature.20,31 This was largely due to the villager’s mindset towards arachnid bites or stings. Upon a scorpion sting accident, adult victims are likely to stay at home if they experience mild symptoms and to relieve their pain by cleaning the sting site using traditional home remedies. Adult victims likely seek medication attention only if the symptoms of scorpion stings are moderate to severe. It may take as long as one to two days after the incident has occurred. Children scorpions sting victims, however, were immediately admitted to the hospital because of intolerance to pain. For adults, a longer elapsed time increases the probability of developing systemic effects and experiencing an “autonomic storm”, thus classifying the patient’s symptoms as class III. If adult patients recognise the severity of the medical threat and are hospitalised early, medication management and monitoring would likely prevent systemic effects.
Despite the lack of ecological surveys in Eritrea, neighbouring Sudan has previously conducted ecological surveys to identify four scorpion species (C. werneri, L. quinquestriatus, O. olivaceus, and P. abyssinicus) prevalent within the Kassala state, bordering the Tesseney subzone.34 This study cannot definitively correlate scorpion species venom with clinical features; however, the likelihood of scorpion species belonging to Sudan being similar to that of the Tesseney subzone is substantial. Despite the colour black being strongly identified with O. olivaceus, correlating scorpion species based on scorpion colour is not possible, as the remaining species are indistinguishable from one another.
In our cases, nifedipine was administered as a replacement for prazosin in patients with Class III symptoms. Nifedipine is often used to treat high blood pressure and is considered a 2nd line treatment with subpar results compared to prazosin. Only 15.2% of patients received either nifedipine and/or SAV to relieve class III symptoms. Diazepam was only administered when SAV was not administered. Diazepam is used as a sedative in patients experiencing convulsions, shock, and/or restlessness. Ampicillin was administered to 1.2% of the patients as prophylaxis for critical patients who were catheterised for an extended period to monitor urine output. In cases of severe pulmonary oedema, neurotoxicity, and circulatory failure, oxygen, sublingual nifedipine, digoxin, furosemide, aminophylline, dopamine, vitamin K, or fresh frozen plasma may be administered.3,10,14 Phenobarbital and dexamethasone may be administered for 48 hours to patients with convulsions.3,10,14
Limitation of the Study
Our study was a prospective study with data limited to a single hospital within the Gash-Barka region, and the species type of scorpions was not identified. Within this region, victims of scorpion stings may not have been registered in a healthcare setting; thus, their experience was not documented. There were also limitations to accurate data recording, including the identification of scorpion colour and definitive rural versus urban criteria when registering patients. Owing to the dependence on subsidence agriculture and the low socio-economic structure across the Gash-Barka region, the criteria for classifying rural and urban areas are not definitive. Thus, an accurate classification of the patients’ place of residence was not possible during the study. Follow-up of patients after discharge was not performed. Thus, fatalities at home days after discharge were often heard via word of mouth and were excluded from the study. During the study period, medication efficacy was difficult to determine because SAV stock ran-out and prazosin therapy were not available because the burden of scorpion sting was not known before.
Conclusion
This study allowed us to appreciate the epidemiological profile and clinical consequences of scorpionism previously undocumented in Teseeney, Eritrea. Localised pain, sweating, and vomiting were the major clinical features of our patient population. Most scorpion string victims were older individuals working in agriculture and were unaware of a typical scorpion habitat while performing daily activities. Although the scorpion sting incidence is higher in adults than in children, scorpion envenomation severity is greater in children than in adults. Envenomation severity is shown by the high frequency of class III symptoms found in children, such as cardiac arrhythmias, convulsions, shock, and semi-consciousness, with children contributing the most to the overall fatality rate.
Recommendation
Our study recommends prevention education programs targeting vulnerable groups (ie young people, new mothers, and children), particularly during summer/warmer seasons when scorpion stings are most prevalent. Additionally, establishing well-equipped healthcare facilities and essential drugs are the best means to manage scorpionism in resource-limited areas.
Abbreviations
MENA, Middle East and North Africa; SAV, Scorpion Antivenom; ED, Emergency Department; WHO, World Health Organization (WHO).
Ethical Approval
Ethical approval was obtained from the zonal branch of the Ministry of Health Research and Ethical Approval Committee (reference number: 3/31/2897). Written informed consent was obtained from the patients or caregivers who participated in the study.
Consent
Written informed consent was obtained from all the patients, and data confidentiality was ensured.
Acknowledgment
Mr. Tewaldemedhine Gebrejesus, BS, Volunteer at the National Tuberculosis and Leprosy Control Program, Ministry of Health, Virginia, USA supports in editing rewriting the article. We want to acknowledge that this article was uploaded as a pre-print with a link: [https://www.medrxiv.org/content/10.1101/2024.01.02.24300701v1]
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This research received no funding.
Disclosure
The authors declare no conflict of interest.
References
1. Kumar R. An update on epidemiology and management practices of Scorpion envenomation in India. J Fam Med Prim Care. 2022;11:4932–4935. doi:10.4103/jfmpc.jfmpc_2300_21
2. Bawaskar HS, Bawaskar PH. Scorpion sting: update. Japi. 2012;60:46–55.
3. Yılmaz F, Arslan ED, Demir A, et al. Epidemiologic and clinical characteristics and outcomes of scorpion sting in the southeastern region of Turkey. Ulus Travma Acil Cerr Derg. 2013;19(5):417–422. doi:10.5505/tjtes.2013.52333
4. Ali NOM, Ali NOM. Scorpion sting in different regions of Sudan: epidemiological and clinical survey among university students. Int J Bioinforma Biomed Eng. 2015;1(2):147–152.
5. Abourazzak S, Achour S, El Arqam L, et al. Epidemiological and clinical characteristics of scorpion stings in children in Fez, Morocco. J Venom Anim Toxins Incl Trop Dis. 2009;15(2):255–267. doi:10.1590/S1678-91992009000200008
6. Chippaux J-P. Emerging options for the management of scorpion stings. Drug Des Devel Ther. 2012;6:165–173. doi:10.2147/DDDT.S24754
7. Pradesh U, Bansal A, Bansal AK, Kumar A. Clinical profile of scorpion sting from north Uttar Pradesh, India. Int J Med Sci Public Heal. 2015;4(1):134–137. doi:10.5455/ijmsph.2015.2009201414
8. Riaño-umbarila L, Ilse VG, Ledezma-candanoza LM, Olamendi-Portugal T, Remi E. Generation of a broadly cross-neutralizing antibody fragment against several Mexican scorpion venoms. Toxins. 2019;11(32):1–17. doi:10.3390/toxins11010032
9. Soren C, Nageswara Rao K. Clinical profile of scorpion sting envenomation in children. Int J Contemp Pediatr. 2016;3(3):865–867.
10. Rao KS, Medicine G, Surgeon C. Clinical study of scorpion sting envenomation - clinical profile, complications, treatment and effect of early treatment with prazocin in preventing the complications. Int J Sci Res. 2021;10(9):7–10.
11. Singhal A, Mannan R, Rampal U. Epidemiology, clinical presentation and final outcome of patients with scorpion bite. J Clin Diagnostic Res. 2009;3(3):1523–1528.
12. Bawaskar HS, Bawaskar PH. Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial. BMJ. 2011;342(jan05 3):c7136–c7136. doi:10.1136/bmj.c7136
13. Murthy KRK. On scorpion envenoming syndrome: problems of medical ethics and accountability in medical research in India. J Venom Anim Toxins. 2002;8(1):3–17. doi:10.1590/S0104-79302002000100002
14. Agrawal A, Kumar A, Consul S, Yadav A. Scorpion bite, a sting to the heart! Indian J Crit Care Med. 2015;19(4):233–236. doi:10.4103/0972-5229.154570
15. LoVecchio F. Scorpion envenomation causing autonomic dysfunction (North Africa, Middle East, Asia, South America, and the Republic of Trinidad and Tobago). 2023.
16. Barish RA, Arnold T. Scorpion Stings. Merck Manual Consumer Version. 2022.
17. Klotz SA, Yates S, Smith SL, Dudley JS, Schmidt JO, Shirazi FM. Scorpion stings and antivenom use in Arizona. Am J Med. 2021;134(8):1034–1038. doi:10.1016/j.amjmed.2021.01.025
18. Khattabi A, Soulaymani-bencheikh R, Achour S, Salmi L-R. Classification of clinical consequences of scorpion stings: consensus development. Trans R Soc Trop Med Hyg. 2011;105(7):364–369. doi:10.1016/j.trstmh.2011.03.007
19. Kassiri H, Mahijan NM, Hasanvand Z, et al. Epidemiological survey on scorpion sting envenomation in south-west, Iran. Zahedan J Reserach Med Sci. 2012;14(8):80–83.
20. Duman A, Dagli B, Akoz A, Avcil M, Orun S, Turkdoğan KA. Importance of antivenom in management of scorpion envenomation with epidemiologic and clinical characteristics. Biomed Res. 2017;28(8):3763–3768.
21. Gupta BD, Parakh M, Purohit A. Management of scorpion sting: prazosin or dobutamine. J Trop Pediatr. 2010;56(2):115–118. doi:10.1093/tropej/fmp070
22. Khatony A, Abdi A, Fatahpour T, Towhidi F. The epidemiology of scorpion stings in tropical areas of Kermanshah province, Iran, during 2008 and 2009. J Venom Anim Toxins Incl Trop Dis. 2015;21(45). doi:10.1186/s40409-015-0045-4
23. Bawaskar HS, Bawaskar PH. Management of Snake Bite and Scorpion Sting. Vol. 60, Quarterly Medical Review. Mumbai: Raptakos, Brett & Co. Ltd.; 2009.
24. Patel M, Singh S, Chakma C, Derashri G. Clinical and socio-epidemiological characteristics of scorpion envenomation in children presented in a tertiary care hospital, India. Casp J Pediatr. 2021;7(2):603–610.
25. Kannan D, Balamurugan MS, Kannan KS, Ravichandran V. Scorpion sting envenomation in children: a study on clinical presentation, clinical grading and outcome. Int J Acad Med Pharm. 2023;5(1):879–883.
26. Baseer KA, Naser MAA. Predictors for mortality in children with scorpion envenomation admitted to pediatric intensive. Am Soc Trop Med Hyg Predict. 2019;101(4):941–945. doi:10.4269/ajtmh.19-0319
27. Boubekeur K, Hadj ML, Selmane S. Demographic and epidemiological characteristics of scorpion envenomation and daily forecasting of scorpion sting counts in Touggourt. Algeria. 2020;42:1–9.
28. Yuvaraja K, Chidambaram N, Umarani R, Bhargav KM. A study on clinical features, complications and management of scorpion sting envenomation at a tertiary care hospital, in rural South India. J Clin Sci Res. 2019;8:140–144. doi:10.4103/JCSR.JCSR_71_19
29. Dehghani R, Kamiabi F, Mohammadi M. Scorpionism by Hemiscorpius spp. in Iran: a review. J Venomous Animals Toxins Includ Trop Dis. 2018;1–10.
30. Bhadani UK, Tripathi M, Sharma S, Pandey R. Scorpion sting envenomation presenting with pulmonary edema in adults: a report of seven cases from Nepal. Indian J Med Sci. 2006;60(1):20–22.
31. Alkahlout BH, Abid MM, Kasim MM, Haneef SM. Epidemiological review of scorpion stings in Qatar. Saudi Med J. 2015;36(7):851–855. doi:10.15537/smj.2015.7.11749
32. Prasad R, Mishra O. Myocardial dysfunction in children with scorpion sting envenomation. Indian Pedatrics. 2015;52:291–2.
33. Feola A, Perrone MA, Piscopo A, Casella F, Della Pietra B, Di Mizio G. Autopsy findings in case of fatal scorpion sting: a systematic review of the literature. Healthc. 2020;8(3):1–11. doi:10.3390/healthcare8030325
34. Siyam M, Dunlop JA, Kovařík F, Mohammad A. Additions to the distribution of Sudanese scorpions. Zoosystematics Evol. 2023;99(1):45–53. doi:10.3897/zse.99.90875
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
